Eli Lilly Says Taltz-Zepbound Combo Shows Sustained Benefits in Psoriatic Arthritis
Eli Lilly said the combination of Taltz and Zepbound showed sustained benefits in psoriatic arthritis.
Related stories
Anthropic Plans to Reserve Up to 20% of IPO for Retail Investors
Anthropic plans to allocate up to 20% of shares in its initial public offering to retail investors. The company may go public as early as next week, according to the report.
L impact | EQUITY | Nov 11, 2026, 04:46 PM UTC
Gabler Group Reports Q3 Results, Raises 2026 Revenue Guidance
Gabler Group reported nine-month revenue of EUR 49.8 million and adjusted EBIT of EUR 15.6 million. Q3 revenue was EUR 22.5 million, with adjusted EBIT of EUR 8.9 million. It raise
M impact | EQUITY | Nov 11, 2026, 04:33 PM UTC
Fiera Milano Raises Full-Year EBITDA Guidance After Nine-Month Results
Fiera Milano reported nine-month revenue of €293.7 million, up 26.7%, and EBITDA of €89.9 million, up 25.6%. Net profit rose 91.7% to €2.7 million. It raised full-year EBITDA guida
M impact | EQUITY | Nov 11, 2026, 04:33 PM UTC
US session market picture: S&P 500 +1.22%, Nasdaq 100 +2.59%; EUR/USD -0.62%, WTI +2.67%, WBD leads volume
US session market picture. US index futures: S and P futures is up 1.22 percent, Nasdaq futures is up 2.59 percent, Dow futures is up 0.06 percent and Russell futures is up 0.81 pe
M impact | EQUITY | Nov 11, 2026, 04:31 PM UTC
U.S. Stocks Extend Gains; S&P 500 Up 1.25%, Nasdaq Up 1.93%
M impact | EQUITY | Nov 11, 2026, 04:30 PM UTC
ICE and OKX to Launch 24/7 Tokenized Stock Trading Nov. 23
Their 50-50 joint venture OKXICE said eligible U.S. customers can begin trading on the platform starting Nov. 23.
L impact | EQUITY | Nov 11, 2026, 04:18 PM UTC